ScholarIQanswers from OpenAlex & ORCID
Laura A. Vallow
ResearcherPublications, citations & collaboration network
Laura A. Vallow is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Laura A. Vallow have?
ScholarIQindexed works
Laura A. Vallow has 161 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Laura A. Vallow have?
ScholarIQcitation count
Laura A. Vallow has 2,540 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Laura A. Vallow?
ScholarIQh-index
Laura A. Vallow has an h-index of 23 in OpenAlex.
What is the i10-index of Laura A. Vallow?
ScholarIQi10-index
Laura A. Vallow has an i10-index of 42 in OpenAlex.
What is the OpenAlex record for Laura A. Vallow?
ScholarIQopenalex
The OpenAlex for Laura A. Vallow is on the source record.
What are the most-cited papers on Laura A. Vallow?
ScholarIQmost cited works
Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial
Frank A. Vicini, Reena S. Cecchini, Julia White, Douglas W. Arthur, Thomas B. Julian, Rachel Rabinovitch, Robert R. Kuske, Patricia A. Ganz, David S. Parda, Michael F. Scheier, Kathryn Winter, Soonmyung Paik, Henry M. Kuerer, Laura A. Vallow, Lori J. Pierce, Eleftherios P. Mamounas, Beryl McCormick, Joseph P. Costantino, Harry D. Bear, Isabelle Germain, G.S. Gustafson, Linda Grossheim, Ivy A. Petersen, Richard Hudes, Walter J. Curran, John Bryant, Norman Wolmark
RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation
Beryl McCormick, Kathryn Winter, Clifford A. Hudis, Henry M. Kuerer, Eileen Rakovitch, Barbara L. Smith, Nour Sneige, Jennifer Moughan, Amit Kumar Shah, Isabelle Germain, Alan C. Hartford, Afshin Rashtian, Eleanor Walker, Albert Yuen, Eric A. Strom, Jeannette L. Wilcox, Laura A. Vallow, William Small, Anthony T. Pu, K. Kerlin, Julia White
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial
Richard G. Margolese, Reena S. Cecchini, Thomas B. Julian, Patricia A. Ganz, Joseph P. Costantino, Laura A. Vallow, Kathy S. Albain, Patrick Whitworth, Mary Cianfrocca, Adam Brufsky, Howard M. Gross, Gamini S. Soori, Judith O. Hopkins, Louis Fehrenbacher, Keren Sturtz, Timothy F. Wozniak, Thomas E. Seay, Eleftherios P. Mamounas, Norman Wolmark
Prognostic factors in Merkel cell carcinoma: Analysis of 240 cases
Tina I. Tarantola, Laura A. Vallow, Michele Y. Halyard, Roger H. Weenig, Karen E. Warschaw, Travis E. Grotz, James W. Jakub, Randall K. Roenigk, Jerry D. Brewer, Amy L. Weaver, Clark C. Otley
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial
Patricia A. Ganz, Reena S. Cecchini, Thomas B. Julian, Richard G. Margolese, Joseph P. Costantino, Laura A. Vallow, Kathy S. Albain, Patrick Whitworth, Mary Cianfrocca, Adam Brufsky, Howard M. Gross, Gamini S. Soori, Judith O. Hopkins, Louis Fehrenbacher, Keren Sturtz, Timothy F. Wozniak, Thomas E. Seay, Eleftherios P. Mamounas, Norman Wolmark